School of Biomedical Sciences, The University of Hong Kong, Hong Kong, China.
CAS Key Laboratory of Quantitative Engineering Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China.
EBioMedicine. 2021 Aug;70:103505. doi: 10.1016/j.ebiom.2021.103505. Epub 2021 Jul 28.
Staphylococcus aureus is a common human pathogen capable of causing diverse illnesses with possible recurrent infections. Although recent studies have highlighted the role of cellular immunity in recurrent infections, the mechanism by which S. aureus evades host responses remains largely unexplored.
This study utilizes in vitro and in vivo infection experiments to investigate difference of pro-inflammatory responses and subsequent adaptive immune responses between adsA mutant and WT S. aureus strain infection.
We demonstrated that adenosine synthase A (AdsA), a potent S. aureus virulence factor, can alter Th17 responses by interfering with NLRP3 inflammasome-mediated IL-1β production. Specifically, S. aureus virulence factor AdsA dampens Th1/Th17 immunity by limiting the release of IL-1β and other Th polarizing cytokines. In particular, AdsA obstructs the release of IL-1β via the adenosine/A2aR/NLRP3 axis. Using a murine infection model, pharmacological inhibition of A2a receptor enhanced S. aureus-specific Th17 responses, whereas inhibition of NLRP3 and caspase-1 downregulated these responses. Our results showed that AdsA contributes to recurrent S. aureus infection by restraining protective Th1/Th17 responses.
Our study provides important mechanistic insights for therapeutic and vaccination strategies against S. aureus infections.
This work was supported by grants from Shenzhen Peacock project (KQTD2015033-117210153), and Guangdong Science and Technology Department (2020B1212030004) to J.H. and China Postdoctoral Science Foundation (2019M663167) to BZZ. We also thank the L & T Charitable Foundation, the Guangdong Science and Technology Department (2020B1212030004), and the Program for Guangdong Introducing Innovative and Entrepreneurial Teams (2019BT02Y198) for their support.
金黄色葡萄球菌是一种常见的人类病原体,能够引起多种疾病,并可能导致反复感染。尽管最近的研究强调了细胞免疫在反复感染中的作用,但金黄色葡萄球菌逃避宿主反应的机制在很大程度上仍未得到探索。
本研究利用体外和体内感染实验,研究了 adsA 突变株和 WT 金黄色葡萄球菌感染之间促炎反应和随后适应性免疫反应的差异。
我们证明了腺苷合酶 A(AdsA),一种强有力的金黄色葡萄球菌毒力因子,可以通过干扰 NLRP3 炎性体介导致炎因子 IL-1β 的产生来改变 Th17 反应。具体来说,金黄色葡萄球菌毒力因子 AdsA 通过限制 IL-1β 和其他 Th 极化细胞因子的释放来抑制 Th1/Th17 免疫。特别是,AdsA 通过腺苷/A2aR/NLRP3 轴来阻止 IL-1β 的释放。使用小鼠感染模型,A2a 受体的药理学抑制增强了金黄色葡萄球菌特异性 Th17 反应,而 NLRP3 和半胱天冬酶-1 的抑制则下调了这些反应。我们的结果表明,AdsA 通过抑制保护性 Th1/Th17 反应,促进了金黄色葡萄球菌的反复感染。
我们的研究为针对金黄色葡萄球菌感染的治疗和疫苗接种策略提供了重要的机制见解。
这项工作得到了深圳市孔雀项目(KQTD2015033-117210153)和广东省科技厅(2020B1212030004)的资助,以及中国博士后科学基金(2019M663167)的资助。我们还要感谢 L&T 慈善基金会、广东省科技厅(2020B1212030004)和广东省引进创新和创业团队计划(2019BT02Y198)对我们的支持。